EDX Medical Group Plc
EDX:AQX

EDX Medical develops and validates digitally-enabled diagnostic products and services to help predict disease risk, inform clinical decision-making and accelerate the development of new medicines in the areas of cancer, heart disease, neurology and infectious diseases.

By translating clinical insights into pragmatic solutions combining advanced biological and digital technologies, EDX Medical seeks to improve the detection of disease risk and personalise disease management, cost-effectively and in a timely fashion. The Directors believe that early disease detection and risk prediction is the most impactful way of reducing deaths and lowering the future costs of healthcare provision globally.